ArticleBMC ophthalmology2025
Interrelationship of diabetic neuropathy, retinopathy and nephropathy in type 2 diabetes mellitus: a cross-sectional analysis.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo investigate the interrelationships between peripheral neuropathy, diabetic retinopathy (DR), and nephropathy in patients with type 2 diabetes mellitus (T2DM), with a specific focus on how DR severity correlates with the presence and severity of diabetic neuropathy and nephropathy.
methodsIn this cross-sectional study, adult patients with at least five years’ duration of T2DM and preserved renal function (eGFR ≥ 60 mL/min/1.73 m²) were evaluated. DR was graded using the International Clinical Diabetic Retinopathy Severity Scale, and DME was assessed by spectral-domain optical coherence tomography. Peripheral neuropathy was quantified via nerve conduction studies (NCS), specifically sural sensory nerve action potential (SNAP) amplitude, while nephropathy was evaluated by urinary albumin-to-creatinine ratio (UACR) and eGFR.
resultsA total of 155, 138, and 94 patients completed neuropathy, retinopathy, and nephropathy assessments, respectively. Among the 138 participants who underwent fundus examination, 60% had proliferative diabetic retinopathy (PDR) and 32% had diabetic macular edema (DME). A significant inverse correlation was found between SNAP amplitude and both DR severity (p = 0.001) and DME presence (p = 0.001), indicating worse nerve conduction in advanced retinal disease. Patients with DME had a fourfold higher likelihood of impaired SNAP values (OR = 4.0; 95% CI: 1.849–8.653). Additionally, DME presence was associated with significantly higher UACR (p = 0.011), and nephropathy severity showed a mild but significant association with DR stage (p = 0.047).
conclusionThe severity of DR and the presence of DME correlate strongly with peripheral neuropathy and increased albuminuria in T2DM patients, reflecting shared microvascular pathology. Retinal findings, particularly DME, may serve as accessible clinical markers for identifying individuals at elevated risk of systemic microvascular complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.